Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries.
van de Munckhof A, Borhani-Haghighi A, Aaron S, Krzywicka K, van Kammen MS, Cordonnier C, Kleinig TJ, Field TS, Poli S, Lemmens R, Scutelnic A, Lindgren E, Duan J, Arslan Y, van Gorp EC, Kremer Hovinga JA, Günther A, Jood K, Tatlisumak T, Putaala J, Heldner MR, Arnold M, de Sousa DA, Wasay M, Arauz A, Conforto AB, Ferro JM, Coutinho JM; Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group. van de Munckhof A, et al. Among authors: kremer hovinga ja. Int J Stroke. 2023 Oct;18(9):1112-1120. doi: 10.1177/17474930231182901. Epub 2023 Jun 30. Int J Stroke. 2023. PMID: 37277922 Free PMC article.
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19.
Scutelnic A, van de Munckhof A, Krzywicka K, van Kammen MS, Lindgren E, Cordonnier C, Kleinig TJ, Field TS, Poli S, Lemmens R, Middeldorp S, Aaron S, Borhani-Haghighi A, Arauz A, Kremer Hovinga JA, Günther A, Putaala J, Wasay M, Conforto AB, de Sousa DA, Jood K, Tatlisumak T, Ferro JM, Coutinho JM, Arnold M, Heldner MR; Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group**. Scutelnic A, et al. Among authors: kremer hovinga ja. Eur Stroke J. 2023 Dec;8(4):1001-1010. doi: 10.1177/23969873231185213. Epub 2023 Jul 11. Eur Stroke J. 2023. PMID: 37434312 Free PMC article.
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19.
Scutelnic A, van de Munckhof A, Miraclin AT, Aaron S, Hameed S, Wasay M, Grosu O, Krzywicka K, Sánchez van Kammen M, Lindgren E, Moreira T, Acampora R, Negro A, Karapanayiotides T, Yaghi S, Revert A, Cuadrado Godia E, Garcia-Madrona S, La Spina P, Grillo F, Giammello F, Nguyen TN, Abdalkader M, Buture A, Sofia Cotelli M, Raposo N, Tsivgoulis G, Candelaresi P, Ciacciarelli A, Mbroh J, Batenkova T, Scoppettuolo P, Zedde M, Pascarella R, Antonenko K, Kristoffersen ES, Kremer Hovinga JA, Jood K, Aguiar de Sousa D, Poli S, Tatlisumak T, Putaala J, Coutinho JM, Ferro JM, Arnold M, Heldner MR. Scutelnic A, et al. Among authors: kremer hovinga ja. Eur Stroke J. 2024 Sep;9(3):676-686. doi: 10.1177/23969873241241885. Epub 2024 Apr 4. Eur Stroke J. 2024. PMID: 38572798 Free PMC article.
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study.
Hammerer-Lercher A, Nilius H, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Kremer Hovinga JA, Vishnu P, Graf L, Bakchoul T, Nagler M. Hammerer-Lercher A, et al. Among authors: kremer hovinga ja. J Thromb Haemost. 2023 Sep;21(9):2559-2568. doi: 10.1016/j.jtha.2023.05.016. Epub 2023 May 27. J Thromb Haemost. 2023. PMID: 37247669 Free article.
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Larsen EL, Nilius H, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Goetze JP, Bakchoul T, Nagler M. Larsen EL, et al. Among authors: kremer hovinga ja. JAMA Netw Open. 2024 Mar 4;7(3):e243786. doi: 10.1001/jamanetworkopen.2024.3786. JAMA Netw Open. 2024. PMID: 38530310 Free PMC article.
The dynamic range of immunoassays for heparin-induced thrombocytopenia.
Nilius H, Naas S, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Bakchoul T, Nakas C, Nagler M. Nilius H, et al. Among authors: kremer hovinga ja. J Thromb Haemost. 2024 Nov 12:S1538-7836(24)00642-1. doi: 10.1016/j.jtha.2024.10.026. Online ahead of print. J Thromb Haemost. 2024. PMID: 39536820 Free article.
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Nilius H, Cuker A, Haug S, Nakas C, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Kremer Hovinga JA, Vishnu P, Graf L, Kashev A, Sznitman R, Bakchoul T, Nagler M. Nilius H, et al. Among authors: kremer hovinga ja. EClinicalMedicine. 2022 Nov 24;55:101745. doi: 10.1016/j.eclinm.2022.101745. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457646 Free PMC article.
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series.
Ruberti A, Kremer Hovinga JA, Nappi F, Vettese A, Bianchi E, Fernandes E, Galfetti E, Monotti R, Paul P, Regazzoni S, Valente D, Rossi D, Stussi G, Gerber B. Ruberti A, et al. Among authors: kremer hovinga ja. Swiss Med Wkly. 2023 Mar 31;153:40048. doi: 10.57187/smw.2023.40048. Swiss Med Wkly. 2023. PMID: 37021783 Free article.
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura.
Pavenski K, Scully M, Coppo P, Cataland S, Knöbl P, Peyvandi F, Kremer Hovinga JA, de la Rubia J, Khan U, Marques AP, Gunawardena S. Pavenski K, et al. Among authors: kremer hovinga ja. Res Pract Thromb Haemost. 2024 Jul 15;8(5):102512. doi: 10.1016/j.rpth.2024.102512. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39221451 Free PMC article.
152 results